Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
Donato P, Morton A, Yaxley J, Ranasinghe S, Teloken PE, Kyle S, Coughlin G, Esler R, Dunglison N, Gardiner RA, Roberts MJ. Donato P, et al. Among authors: kyle s. Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1843-1851. doi: 10.1007/s00259-019-04620-0. Epub 2020 Jan 7. Eur J Nucl Med Mol Imaging. 2020. PMID: 31912257
Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions "invisible" on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology.
Donato P, Roberts MJ, Morton A, Kyle S, Coughlin G, Esler R, Dunglison N, Gardiner RA, Yaxley J. Donato P, et al. Among authors: kyle s. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):20-30. doi: 10.1007/s00259-018-4160-7. Epub 2018 Sep 19. Eur J Nucl Med Mol Imaging. 2019. PMID: 30229528
68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer.
Roberts MJ, Morton A, Donato P, Kyle S, Pattison DA, Thomas P, Coughlin G, Esler R, Dunglison N, Gardiner RA, Doi SA, Emmett L, Yaxley J. Roberts MJ, et al. Among authors: kyle s. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):477-482. doi: 10.1007/s00259-020-04944-2. Epub 2020 Jul 22. Eur J Nucl Med Mol Imaging. 2021. PMID: 32696091
Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer.
Roberts MJ, Morton A, Donato P, Kyle S, Pattison DA, Thomas P, Coughlin G, Esler R, Dunglison N, Gardiner RA, Doi SA, Emmett L, Yaxley J. Roberts MJ, et al. Among authors: kyle s. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):655-656. doi: 10.1007/s00259-020-04983-9. Eur J Nucl Med Mol Imaging. 2021. PMID: 32918575 No abstract available.
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison.
Tariq A, Kwok M, Pearce A, Rhee H, Kyle S, Marsh P, Raveenthiran S, Wong D, McBean R, Westera J, Dunglison N, Esler R, Navaratnam A, Yaxley JW, Thomas P, Pattison DA, Roberts MJ. Tariq A, et al. Among authors: kyle s. Urol Oncol. 2022 Feb;40(2):66.e1-66.e9. doi: 10.1016/j.urolonc.2021.11.006. Epub 2021 Dec 8. Urol Oncol. 2022. PMID: 34895817
Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT).
Tariq A, McGeorge S, Pearce A, Rhee H, Wood S, Kyle S, Marsh P, Raveenthiran S, Wong D, McBean R, Westera J, Dunglison N, Esler R, Navaratnam A, Yaxley J, Thomas P, Pattison DA, Roberts MJ. Tariq A, et al. Among authors: kyle s. Urol Oncol. 2022 Jun;40(6):276.e1-276.e9. doi: 10.1016/j.urolonc.2022.03.007. Epub 2022 Apr 22. Urol Oncol. 2022. PMID: 35466037
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.
Pathmanathan S, Tariq A, Pearce A, Rhee H, Kyle S, Raveenthiran S, Wong D, McBean R, Marsh P, Goodman S, Dhiantravan N, Esler R, Dunglison N, Navaratnam A, Yaxley J, Thomas P, Pattison DA, Goh JC, Gan CL, Roberts MJ. Pathmanathan S, et al. Among authors: kyle s. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):295-303. doi: 10.1007/s00259-023-06380-4. Epub 2023 Aug 18. Eur J Nucl Med Mol Imaging. 2023. PMID: 37592084 Free PMC article.
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort.
Tariq A, Pearce A, Rhee H, Kyle S, Raveenthiran S, Pelecanos A, Gan CL, Goh JC, Wong D, McBean R, Marsh P, Goodman S, Dunglison N, Esler R, Navaratnam A, Yaxley JW, Thomas P, Pattison DA, Roberts MJ. Tariq A, et al. Among authors: kyle s. Eur Urol Focus. 2024 Sep;10(5):770-778. doi: 10.1016/j.euf.2023.12.004. Epub 2024 Jan 8. Eur Urol Focus. 2024. PMID: 38195354 Free article.
290 results